Trusted by patient organisations and research partners.
Our Mission
Our mission is to drive change in rare & unmet diseases by addressing challenges through high-quality research and data, robust analysis and actionable evidence.
.jpg)
Committed to the patient
We place patients at the heart of everything we do. At the same time, we recognise that rare & unmet conditions affect a broad range of stakeholders. Our research is designed to capture these diverse perspectives, ensuring that the experiences and needs of all those impacted are reflected.
To drive meaningful change, we bring together a wide network of stakeholders; patients, caregivers, clinicians, the life sciences industry, patient organisations, and policy makers. Creating collaborative solutions grounded in real-world insight.
How we do it
Evidence and Insights
Generation
We generate data, insights, and evidence using qualitative, quantitative and mixed methods, to gather outcomes, characterise disease burden, elicit preferences and quantify impact of rare and unmet diseases.
Health Economics and
Data Science
We apply rigorous analytical methods to support the interpretation and application of real-world data in rare diseases. Including statistical analysis, regression, cost-effectiveness, and budget impact modelling.
Evidence and Insights Communication
We communicate research findings through a range of formats, including journal publications, conference presentations and bespoke interactive dashboards, tailored to different audiences and settings.
Education and
Engagement
We engage with multiple stakeholders to educate them on the latest evidence and insights available. Including presentations, educational materials and more.
Who we support
We believe in providing high quality robust evidence centred around the people affected by a condition
We support Pharmaceutical, Biotechnology and Medical Device companies. Specialising in rare & unmet diseases.
We support healthcare systems and providers make decisions with high quality evidence.
Patient Organisations
We support Patient Advocacy Groups with evidence based advocacy.
"
For a number of years DHT has been a strategic partner to the Haemophilia Society, a UK charity that supports people with genetic bleeding disorders.
Their expertise in evidence based decision making has helped us demonstrate our impact, secure funding and give people with bleeding disorders greater understanding of an access to the best treatment options available.
